Vaxiion Therapeutics
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors (NCT05901285) | Vaxiion Therapeutics | 2023-11-02 |
| A Phase 1 Study of Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer (NCT03854721) | Vaxiion Therapeutics | 2019-05-10 |
Track Vaxiion Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.